So my point is, where is the accountability? Where is the accountability for drug manufacturers not tracking and using that information with the Drug Enforcement Administration to work cost-effectively to try to stop this kind of distribution?
Cantwell questions the lack of accountability for drug manufacturers in opioid distribution.
Share
More from Maria Cantwell
My constituents were outraged by the $1.8 billion slush fund, but the offer of blanket immunity from any tax enforcement claims was especially appalling.
The data sharing at issue in this case by the [IRS] and [ICE] violates the express terms of the statute and ignores its history.
Making sure that the IRS is funded and staffed is essential to having a fair system.
Other voices in this conversation
